| pubmed-article:7073340 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7073340 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:7073340 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:7073340 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:7073340 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7073340 | pubmed:dateCreated | 1982-6-24 | lld:pubmed |
| pubmed-article:7073340 | pubmed:abstractText | A nephelometric assay of concanavalin-A binding of serum acute phase proteins (con-A binding) has been used in cross-sectional and sequential studies of disease activity in rheumatoid arthritis (RA). Con-A binding correlated well with blood viscosity, C-reactive protein, and other individual acute phase reactants in patients with active RA. Twenty-four patients were treated for 6 months with D-penicillamine and assessed clinically and seriologically. Clinical improvement was accompanied by significant falls in both C-reactive protein and con-A binding, although the serological changes did not always occur in parallel in individual patients. The advantages of this simple, cheap assay of acute phase proteins are discussed. | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7073340 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7073340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7073340 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7073340 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7073340 | pubmed:issn | 0003-4967 | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:DieppeP APA | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:WarrenCC | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:KohlHH | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:JonesH EHE | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:MartinM FMF | lld:pubmed |
| pubmed-article:7073340 | pubmed:author | pubmed-author:WhicherJJ | lld:pubmed |
| pubmed-article:7073340 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7073340 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:7073340 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7073340 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7073340 | pubmed:pagination | 133-6 | lld:pubmed |
| pubmed-article:7073340 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:meshHeading | pubmed-meshheading:7073340-... | lld:pubmed |
| pubmed-article:7073340 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:7073340 | pubmed:articleTitle | Serum concanavalin-A binding in rheumatoid arthritis. | lld:pubmed |
| pubmed-article:7073340 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7073340 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7073340 | lld:pubmed |
